A Study of Potential Treatment-Responsive Biomarkers and Clinical Outcomes in Hunter Syndrome
Clinical trial NCT04007536 · COMPLETED
Trial details
- NCT number
- NCT04007536
- Sponsor
- Denali Therapeutics Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-23
- Primary completion
- 2024-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.